MENU
+Compare
ACLX
Stock ticker: NASDAQ
AS OF
Jun 5, 04:59 PM (EDT)
Price
$66.20
Change
+$0.72 (+1.10%)
Capitalization
3.61B

ACLX Arcellx Forecast, Technical & Fundamental Analysis

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases... Show more

ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ACLX with price predictions
Jun 04, 2025

ACLX's RSI Oscillator ascending out of oversold territory

The RSI Indicator for ACLX moved out of oversold territory on May 08, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 16 similar instances when the indicator left oversold territory. In of the 16 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 20, 2025. You may want to consider a long position or call options on ACLX as a result. In of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACLX just turned positive on May 20, 2025. Looking at past instances where ACLX's MACD turned positive, the stock continued to rise in of 29 cases over the following month. The odds of a continued upward trend are .

ACLX moved above its 50-day moving average on June 03, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ACLX crossed bullishly above the 50-day moving average on June 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACLX advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

ACLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 33 cases where ACLX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.658) is normal, around the industry mean (16.306). P/E Ratio (0.000) is within average values for comparable stocks, (59.921). ACLX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (46.296) is also within normal values, averaging (265.014).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACLX is expected to report earnings to fall 9.73% to -101 cents per share on August 18

Arcellx ACLX Stock Earnings Reports
Q2'25
Est.
$-1.02
Q1'25
Missed
by $0.37
Q4'24
Missed
by $0.31
Q3'24
Missed
by $0.14
Q2'24
Beat
by $0.01
The last earnings report on May 08 showed earnings per share of -112 cents, missing the estimate of -75 cents. With 161.81K shares outstanding, the current market capitalization sits at 3.61B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
800 Bridge Parkway
Phone
+1 240 327-0603
Employees
130
Web
https://www.arcellx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAMHX35.580.12
+0.34%
American Funds American Balanced R2E
GGHYX37.45N/A
N/A
Invesco Health Care Y
GDSRX23.76N/A
N/A
Goldman Sachs Small Cap Eq Insghts R
JEVIX9.33N/A
N/A
JHancock Disciplined Value Em Mkts Eq I
STLYX36.43N/A
N/A
SEI Tax-Managed Large Cap Y (SIMT)

ACLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.52%
CGON - ACLX
57%
Loosely correlated
-0.78%
KRYS - ACLX
56%
Loosely correlated
+0.86%
RNA - ACLX
55%
Loosely correlated
-0.55%
BEAM - ACLX
54%
Loosely correlated
+1.60%
XNCR - ACLX
53%
Loosely correlated
-0.44%
More